Recognition of illness associated with the intentional release of a biologic agent

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  On September 11, 2001, following the terrorist incidents in New York City and Washington, D.C., CDC recommended heightened surveillance for any unusual disease occurrence or increased numbers of illnesses that might be associated with the terrorist attacks. Subsequently, cases of anthrax in Florida and New York City have demonstrated the risks associated with intentional release of biologic agents. This report provides guidance for health-care providers and public health personnel about recognizing illnesses or patterns of illness that might be associated with intentional release of biologic agents.
• Subjects:
  Anthrax Bioterrorism Botulism Clinical Laboratory Techniques Hemorrhagic Fevers, Viral Humans Infection Control Plague Public Health Administration Public Health Practice Smallpox Specimen Handling Tularemia

  More +
• Source:
  MMWR. Morbidity and mortality weekly report. 2001; 50(41):893-7.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  11686473
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  5 pdf pages
• Volume:
  50
• Issue:
  41
• Collection(s):
  Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:3b1d8f8b9a78c0577a14a93c5453bba93ea2c650c301901af3be44d35cffb46aec3b061cadf163b381938ef78149279fb21e92d106fe9c42ecaef61b7fcb3808
• Download URL:
  https://stacks.cdc.gov/view/cdc/7547/cdc_7547_DS1.pdf
• File Type:
  [PDF - 34.72 KB ]